Response Genetics Inc (RGDXQ)
0.00
USD |
OTCM |
May 17, 16:00
Response Genetics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2015 | -2.180 |
| December 31, 2014 | 0.1898 |
| September 30, 2014 | 4.697 |
| June 30, 2014 | 0.2992 |
| March 31, 2014 | 0.4107 |
| December 31, 2013 | 0.1736 |
| September 30, 2013 | 0.2569 |
| June 30, 2013 | 0.2628 |
| March 31, 2013 | 0.1995 |
| December 31, 2012 | -1.844 |
| September 30, 2012 | -0.1253 |
| June 30, 2012 | -0.1454 |
| March 31, 2012 | -0.2302 |
| December 31, 2011 | -0.1629 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | -0.1098 |
| December 31, 2006 | -0.1303 |
| September 30, 2006 | -0.1576 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.5683 |
| Asensus Surgical Inc | 0.00 |
| Vitro Biopharma Inc (DELISTED) | 8.538 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.78M |
| Total Liabilities (Quarterly) | 15.72M |
| Shareholders Equity (Quarterly) | -4.937M |